Literature DB >> 35255409

CARD11 signaling in regulatory T cell development and function.

Nicole M Carter1, Joel L Pomerantz2.   

Abstract

Regulatory T cells (Tregs) are a critical subset of CD4 T cells that modulate the immune response to prevent autoimmunity and chronic inflammation. CARD11, a signaling hub and scaffold protein that links antigen receptor engagement to activation of NF-κB and other downstream signaling pathways, is essential for the development and function of thymic Tregs. Mouse models with deficiencies in CARD11 and CARD11-associated signaling components generally have Treg defects, but some mouse models develop overt autoimmunity and inflammatory disease whereas others do not. Inhibition of CARD11 signaling in Tregs within the tumor microenvironment can potentially promote anti-tumor immunity. In this review, we summarize evidence for the involvement of CARD11 signaling in Treg development and function and discuss key unanswered questions and future research opportunities.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bcl10; CARD11; MALT1; NF-kappaB; Treg

Mesh:

Substances:

Year:  2022        PMID: 35255409      PMCID: PMC9149070          DOI: 10.1016/j.jbior.2022.100890

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  54 in total

1.  The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.

Authors:  Yisong Y Wan; Hongbo Chi; Min Xie; Michael D Schneider; Richard A Flavell
Journal:  Nat Immunol       Date:  2006-06-25       Impact factor: 25.606

2.  Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease.

Authors:  Batsukh Dorjbal; Jeffrey R Stinson; Chi A Ma; Michael A Weinreich; Bahar Miraghazadeh; Julia M Hartberger; Stefanie Frey-Jakobs; Stephan Weidinger; Lena Moebus; Andre Franke; Alejandro A Schäffer; Alla Bulashevska; Sebastian Fuchs; Stephan Ehl; Sandhya Limaye; Peter D Arkwright; Tracy A Briggs; Claire Langley; Claire Bethune; Andrew F Whyte; Hana Alachkar; Sergey Nejentsev; Thomas DiMaggio; Celeste G Nelson; Kelly D Stone; Martha Nason; Erica H Brittain; Andrew J Oler; Daniel P Veltri; T Ronan Leahy; Niall Conlon; Maria C Poli; Arturo Borzutzky; Jeffrey I Cohen; Joie Davis; Michele P Lambert; Neil Romberg; Kathleen E Sullivan; Kenneth Paris; Alexandra F Freeman; Laura Lucas; Shanmuganathan Chandrakasan; Sinisa Savic; Sophie Hambleton; Smita Y Patel; Michael B Jordan; Amy Theos; Jeffrey Lebensburger; T Prescott Atkinson; Troy R Torgerson; Ivan K Chinn; Joshua D Milner; Bodo Grimbacher; Matthew C Cook; Andrew L Snow
Journal:  J Allergy Clin Immunol       Date:  2018-08-28       Impact factor: 10.793

3.  Differential requirement for CARMA1 in agonist-selected T-cell development.

Authors:  Benjamin D Medoff; Barry P Sandall; Aimee Landry; Kiyotaka Nagahama; Atsushi Mizoguchi; Andrew D Luster; Ramnik J Xavier
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

4.  An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function.

Authors:  Hyunju Oh; Yenkel Grinberg-Bleyer; Will Liao; Dillon Maloney; Pingzhang Wang; Zikai Wu; Jiguang Wang; Dev M Bhatt; Nicole Heise; Roland M Schmid; Matthew S Hayden; Ulf Klein; Raul Rabadan; Sankar Ghosh
Journal:  Immunity       Date:  2017-09-07       Impact factor: 31.745

5.  Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.

Authors:  Fabienne Charbit-Henrion; Anja K Jeverica; Bernadette Bègue; Gasper Markelj; Marianna Parlato; Simona Lucija Avčin; Isabelle Callebaut; Marc Bras; Mélanie Parisot; Janez Jazbec; Matjaz Homan; Alojz Ihan; Frédéric Rieux-Laucat; Marie-Claude Stolzenberg; Frank M Ruemmele; Tadej Avčin; Nadine Cerf-Bensussan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-03       Impact factor: 2.839

6.  MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.

Authors:  Jong W Yu; Sandy Hoffman; Allison M Beal; Angela Dykon; Michael A Ringenberg; Anna C Hughes; Lauren Dare; Amber D Anderson; Joshua Finger; Viera Kasparcova; David Rickard; Scott B Berger; Joshi Ramanjulu; John G Emery; Peter J Gough; John Bertin; Kevin P Foley
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

7.  Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.

Authors:  Conor Mc Guire; Lynn Elton; Peter Wieghofer; Jens Staal; Sofie Voet; Annelies Demeyer; Daniel Nagel; Daniel Krappmann; Marco Prinz; Rudi Beyaert; Geert van Loo
Journal:  J Neuroinflammation       Date:  2014-07-21       Impact factor: 8.322

8.  Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.

Authors:  Kea Martin; Ursula Junker; Elaine Tritto; Esther Sutter; Tina Rubic-Schneider; Hannah Morgan; Satoru Niwa; Jianping Li; Achim Schlapbach; Dana Walker; Marc Bigaud; Christian Beerli; Amanda Littlewood-Evans; Bettina Rudolph; Marc Laisney; David Ledieu; Karen Beltz; Jean Quancard; Frédéric Bornancin; Natasa Zamurovic Ribrioux; Thomas Calzascia
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

9.  Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery.

Authors:  Michael J Barnes; Philippe Krebs; Nathaniel Harris; Celine Eidenschenk; Rosana Gonzalez-Quintial; Carrie N Arnold; Karine Crozat; Sosathya Sovath; Eva Marie Moresco; Argyrios N Theofilopoulos; Bruce Beutler; Kasper Hoebe
Journal:  PLoS Biol       Date:  2009-03-03       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.